Eli Lilly and Company (NYSE:LLY) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 30, the company ...

The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain markets from September 1 ...

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

Discover key highlights in healthcare stocks, including UnitedHealth's surge after a Buffett stake, Eli Lilly lawsuits, Trump pharma tariffs & Bayer's ...

Steroid dealers using social media and beauty salons to sell cheap Chinese copies of weight-loss drugs, experts warn ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

U.S. drugmaker Eli Lilly & Co. has increased prices of its popular diabetes and anti-obesity drug Mounjaro in Canada, ...

The programme includes a nationwide competition for NHS organisations to submit innovative new models of obesity care.